P3 Health Partners Inc.
PIII
$5.19
$0.152.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.61% | -110.10% | -104.58% | -135.14% | 18.71% |
| Total Depreciation and Amortization | -2.56% | -1.88% | -1.27% | -0.71% | -0.58% |
| Total Amortization of Deferred Charges | 14,221.25% | -81.57% | -81.57% | -81.57% | -80.25% |
| Total Other Non-Cash Items | -6.56% | -3.27% | -9.51% | -0.31% | -94.96% |
| Change in Net Operating Assets | -30.84% | 10.26% | 93.68% | 149.85% | 399.10% |
| Cash from Operations | -78.50% | -141.84% | -70.82% | -44.85% | 25.34% |
| Capital Expenditure | -156.13% | -- | -- | -- | 110.66% |
| Sale of Property, Plant, and Equipment | -102.83% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -103.58% | 8,428.57% | 1,165.66% | 895.02% | 864.81% |
| Total Debt Issued | 362.19% | 306.38% | 819.92% | 537.74% | -7.66% |
| Total Debt Repaid | -1,723.99% | -2,843.75% | -7,082.33% | -- | -- |
| Issuance of Common Stock | -99.94% | -99.94% | -51.63% | -51.57% | -51.60% |
| Repurchase of Common Stock | 97.94% | -106.57% | -117.74% | -148.67% | -2,816.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 77.37% | 46.67% | -115.23% | -75.29% | -352.02% |
| Cash from Financing | 45.85% | 14.85% | 20.89% | -1.56% | -44.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -378.06% | -406.03% | -62.44% | -85.91% | -51.73% |